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Abstract 34 
Context: The magnitude of exercise-induced weight loss depends on the extent of compensatory 35 
responses. An increase in energy intake is likely to result from changes in the appetite control system 36 
towards an orexigenic environment; however, few studies have measured how exercise impacts on 37 
both orexigenic and anorexigenic peptides. 38 
Objective: To investigate the effects of medium-term exercise on fasting/postprandial levels of 39 
appetite-related hormones, and subjective appetite sensations in overweight/obese individuals.  40 
Design and setting: Longitudinal study conducted in a university research center.  41 
Participants and intervention: Twenty-two sedentary overweight/obese individuals 42 
(age:36.9±8.3years, BMI:31.3±3.3kg/m2) took part in a 12-week supervised exercise programme (5 43 
times/week, 75% maxHR) and were requested not to change their food intake during the study.  44 
Main outcome measures: Changes in body weight, fasting/postprandial plasma levels of glucose, 45 
insulin, total and acylated ghrelin (TG and AG), peptide YY (PYY) and glucagon-like peptide-1 46 
(GLP-1) and feelings of appetite. 47 
Results: Exercise resulted in a significant reduction in body weight and fasting insulin and an 48 
increase in AG plasma levels and fasting hunger sensations. A significant reduction in postprandial 49 
insulin plasma levels and tendency towards an increase in the delayed release of GLP-1 (90-180 min) 50 
were also observed after exercise, as well as a significant increase (127%) in the suppression of AG 51 
postprandially.  52 
Conclusions: Exercise-induced weight loss is associated with physiological and biopsychological 53 
changes towards an increased drive to eat in the fasting state. However, this seems to be balanced by 54 
an improved satiety response to a meal and improved sensitivity of the appetite control system. 55 
 56 
 57 
 58 
 59 
 60 
 61 
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Introduction 62 
Increasing physical activity (PA) levels has been proposed as a good strategy to tackle obesity (1;2). 63 
However, we have shown that weight loss in response to exercise is neither inevitable nor consistent 64 
(3). It is likely that some individuals are susceptible to the weight loss benefits of exercise, while 65 
others are resistant.  66 
Almost three decades ago it was proposed that “exercise may stimulate the appetite so that persons 67 
who exercise increase their eating and do not lose as much weight as expected” (4). It is generally 68 
accepted that the appetite regulatory system will quickly defend impositions that promote a negative 69 
energy balance (EB). Metabolic and behavioural compensatory responses, targeting both sides of the 70 
EB equation, are likely to influence the magnitude of weight loss in response to exercise. Individual 71 
variability in those compensatory responses could partly explain inter-individual variation in exercise-72 
induced weight loss and why some individuals fail to lose weight with exercise (5). It has been 73 
proposed that the difficulty in maintaining EB in a weight-reduced state is a consequence of a 74 
“compromised appetite control”. Weight loss may lead to counter-regulatory adaptations possibly 75 
through upregulation of orexigenic (ghrelin) and downregulation of anorexigenic (polypeptide YY 76 
(PYY) and glucagon-like peptide-1 (GLP-1)) peptides (6). These peptides are expected to serve as 77 
food cues and modulate the expression of feeding behaviour by increasing hunger and EI, in an 78 
attempt to automatically restore EB and prevent further weight loss.  79 
We have recently shown that participants who lose less weight than expected in response to a 80 
supervised exercise programme experience a compensatory increase in habitual energy intake (EI) 81 
accompanied by an increased drive to eat (3). The increase in EI experienced by some in response to 82 
an imposed exercise programme could theoretically be driven by an increase in the release of ghrelin, 83 
an orexigenic peptide, and/or a blunted release of satiety gut peptides in response to a fixed meal.  84 
Not much research has been devoted to the impact of long-term exercise on the release of appetite-85 
related hormones in the obese population and how that relates to weight loss (7). Although it has 86 
already been shown that exercise-induced weight loss induces a compensatory increase in total ghrelin 87 
(TG) plasma levels (8-10), no significant changes have been reported on acylated ghrelin (AG) 88 
(10;11). This is the molecular form which is able to bind to the growth hormone-secretagogue 89 
 4
receptor, cross the blood-brain barrier and, therefore, exert its orexigenic effects at the hypothalamic 90 
level. However, the previous two studies were performed in children and adolescents, and in the latter 91 
study no significant changes in body weight were observed (11). Evidence regarding the impact of 92 
chronic exercise on the plasma levels of satiety gut peptides is also relatively scarce, particularly in 93 
the obese population. However, two studies in adolescents have reported an increase in the release of 94 
satiety peptides in response to medium- to long-term exercise  (11;12).  95 
The aim of this study was to investigate the effects of a 12-week supervised exercise programme on 96 
fasting and postprandial plasma levels of appetite-related hormones, and subjective feelings of 97 
appetite in sedentary overweight/obese individuals and to determine if any changes were correlated 98 
with the magnitude of exercise-induced weight loss. 99 
 100 
Subjects and methods  101 
Participants 102 
Twenty-two overweight and obese healthy sedentary volunteers (eight men and fourteen women) were 103 
recruited for this study through advertisements posted at the University and surrounding community. 104 
Inclusion criteria were as follows: age between 18-60 years old, BMI between 27-35 kg/m2, weight 105 
stable (<2kg variation in body weight on the last three months), not currently dieting to lose weight, 106 
not taking any medication known to affect body weight or appetite, a sedentary lifestyle and a restraint 107 
score ≤12 derived from the Three Factor Eating Behaviour Questionnaire (TFEQ) (13). Sedentary 108 
lifestyle was defined as not engaged in strenuous work or in regular brisk leisure PA more than once a 109 
week or in light exercise for more than 20 minutes/day more than 3 times/week and was assessed 110 
through an exercise history relating to the three months prior to the study.  111 
This study was conducted according to the guidelines laid down in the Declaration of Helsinki. All 112 
participants gave written consent before enrolling in the study and approval was obtained from the 113 
regional Ethics Committee (Midt-Norge, Trondheim, Norway).  114 
 115 
 116 
 117 
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Study Protocol 118 
Participants underwent a 12-week supervised exercise programme and were asked to maintain their 119 
normal diet throughout the study. Several measurements were performed before and after the 120 
intervention including: body weight and composition, maximal oxygen consumption (VO2max), 121 
resting metabolic rate, habitual food intake, fasting and postprandial release of appetite-related 122 
hormones and subjective feelings of appetite.  123 
 124 
A. Exercise programme 125 
Participants underwent a 12-week exercise programme (5 days a week) consisting of treadmill 126 
walking or running. The programme was individually designed in order to induce a 500 kcal energy 127 
deficit per session at approximately 75% of their maximal heart rate (maxHR). All exercise sessions 128 
were supervised in the research unit. Subjects wore a POLAR (S610, POLAR, Finland) heart rate 129 
monitor during each exercise session. To account for changes in fitness and body weight, a 130 
submaximal VO2max test was performed at week 4 and 8 to recalculate the exercise duration needed 131 
to induce 500 kcal EE.  132 
 133 
B. VO2max measurement  134 
VO2max was measured during uphill treadmill walking or running (Woodway PPS 55 Med, Munich, 135 
Germany), using the system Oxigen Pro (Viasys Healthcare, Hoechberg, Germany). A warm-up 136 
period of 10 min (50-60% of HRmax) preceded the test. A plateauing of oxygen uptake (VO2), 137 
despite increased work load and a respiratory exchange ratio ≥1.05 were used as criteria for VO2max. 138 
HR was measured during the test (Polar type 610, Polar Electro, Kempele, Finland) and maxHR was 139 
defined by adding 5 beats/min to the highest HR value obtained during the VO2max test. 140 
 141 
C. Body composition 142 
Body composition was measured using Dual-energy X-ray absorptiometry (Dexa, Hologic Discovery-143 
A, Integrity Medical systems Inc, Florida, USA). 144 
  145 
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D. Resting metabolic rate (RMR) 146 
RMR was measured by indirect calorimetry (Deltatrac II metabolic monitor; Datex-Ohmeda Division, 147 
Helsinki, Finland) with the participants fasted and laying supine for 30 min under a ventilated hood. 148 
Respiratory Quotient (RQ) was calculated as the ratio of carbon dioxide produced to oxygen 149 
consumed. 150 
 151 
E. Habitual Food intake  152 
Participants were asked to maintain their normal diet throughout the study. This was verified by a 153 
three-day estimated food diary (including at least one weekend day) using appropriate photographic 154 
booklets and household measures to improve the validity of portion size estimates, before the start of 155 
the study and at week 12 of the exercise intervention.  156 
 157 
F. Blood sampling and subjective measures of appetite 158 
Participants visited the research unit in the fasted state (at least 12 hours fast), before and after the 12 159 
week exercise intervention (at least 48 hours after the last exercise session to exclude acute effects of 160 
exercise). On each occasion an intravenous cannula was inserted into an antecubital vein. Two fasting 161 
baseline blood samples (-10 and 0 minutes) were taken and participants asked to rate their baseline 162 
appetite using visual analogue scales (VAS). Participants were then instructed to consume a standard 163 
breakfast (time=zero) (consisting of bread, orange juice, milk, cheese and jam: 600 kcal, 17% protein, 164 
35% fat, 48% carbohydrate) within 10 minutes. Blood samples were taken at regular intervals for a 165 
period of 3 hours (every 15 minutes in the first hour and every half an hour in the second and third 166 
hour) and subjective appetite was assessed throughout the morning using VAS. Subjective feelings of 167 
hunger (“How hungry do you feel?”), fullness (“How full do you feel?”), desire to eat (How much 168 
would you like to eat?) and prospective food consumption (How much do you think you can eat?) 169 
were assessed using 10cm self-rated VAS, as previously described (14), before and after breakfast and 170 
at every half an hour up to 3h. 171 
 172 
 173 
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G. Hormone measurement 174 
Venous blood was collected into potassium-oxalate tubes for analysis of glucose and potassium 175 
EDTA-coated tubes, containing 500KIU aprotinin (Pentapharm, Basle, Switzerland)/ml whole blood, 176 
for the measurement of insulin and gut peptides. Samples were then centrifuged at 2000 g for 10 177 
minutes and plasma analyzed immediately (for glucose) or kept at –20° C for later analyses. For the 178 
measurement of AG, 50 μl of a 1 N hydrochloric acid solution and 10 μl of Phenylmethylsulfonyl 179 
fluoride (Sigma, Schnelldorf, Germany) (10 mg/ml of isopropanol) was added to each ml of plasma 180 
immediately after centrifugation. All samples were batch analysed at the end of the study to reduce 181 
inter-assay variability.  182 
Glucose was measured using standard laboratory techniques. Insulin, TG and AG were quantified 183 
using human-specific RIA kits (Linco Research, St Charles, USA) and GLP-1 and PYY “in house” 184 
RIA methods (15;16). The sensitivity of the assays was 14 pmol/L for insulin, 93 pg/ml for TG, 7.8 185 
pg/ml for AG, 1 pmol/L for GLP-1 and 2 pmol/l for PYY.  All samples were assayed in duplicate and 186 
baseline and end samples of the same individual were analysed in the same batch. The intra-assay 187 
coefficient of variation was of <10% for insulin, TG and AG and <5% for GLP-1 and PYY. 188 
 189 
H. Measurement of insulin sensitivity 190 
Fasting insulin sensitivity (SI), as a percentage of a normal reference population (%S), was calculated 191 
using the HOMA2 Calculator version 2.2 (University of Oxford, Oxford, UK) (17).  192 
 193 
Statistical analysis  194 
Statistical analysis was carried out using SPSS 15.0 (SPSS Inc., Chicago, IL). All variables were 195 
checked regarding their normal distribution using the Shapiro-Wilk test. Statistical significance was 196 
assumed at P<0.05, unless otherwise stated.  197 
Differences in fasting plasma levels of metabolites/hormones and subjective feelings of appetite 198 
between the two blood sampling mornings (before and after the exercise intervention) were assessed 199 
by paired sample t-tests. The effect of time and exercise (pre- versus post-intervention) on 200 
postprandial levels of metabolites/hormones and subjective feelings of appetite were assessed by a 201 
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repeated measures ANOVA. Amplitude of variation for appetite-related hormones was calculated as 202 
peak minus nadir. For TG and AG, nadir was defined as the single lowest value following breakfast 203 
and peak as the single highest value preceding breakfast (average fasting plasma level). For GLP-1 204 
and PYY, nadir was average fasting plasma levels and peak the single highest value following 205 
breakfast. 206 
The areas under the curve (AUC) for plasma levels of appetite-related hormones and subjective 207 
feeling of appetite were calculated from before to 180 minutes after breakfast, using the trapezoidal 208 
rule. The effect of the exercise intervention on the AUC of each subjective feeling of appetite was 209 
assessed used paired sample t-tests. Pearson (or Spearman) correlations were used to test the 210 
relationship between changes in the plasma levels of the hormones measured, changes in subjective 211 
feelings of appetite and weight loss. 212 
 213 
Results 214 
Seven women did not complete the exercise programme for several reasons including pregnancy, 215 
injury and time constraints. No significant differences in baseline BMI or fitness levels (VO2max in 216 
ml/kg/min) were observed between completers and non-completers. Results are presented for 15 217 
subjects (7 women and 8 men) with a mean age of 36.9±8.3 years. 218 
 219 
Exercise compliance  220 
Participants who completed the intervention exercised at least 80% of the expected sessions (average 221 
89±5.9%).  222 
 223 
Anthropometry, body composition, RMR, fitness levels and eating behaviour 224 
Changes in anthropometry, body composition, RMR and fitness levels in the 15 participants who 225 
completed the study are shown in table 1. There was a significant reduction in body weight, BMI, 226 
body fat (%), total fat mass and RMR and a significant increase in VO2max after the 12 weeks of 227 
exercise (t=9.46, d.f.=14, P<0.0001; t=9.11, d.f.=14, P<0.0001; t=4.65, d.f.=14, P<0.0001; t=7.981, 228 
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d.f.=14, P<0.0001; t=2.297, d.f.=14, P<0.05 and t=-5.68, d.f.=14; P<0.0001, respectively), but no 229 
change in total FFM (t=1.344, d.f.=14, P=0.2). 230 
 231 
Habitual energy and macronutrient intake   232 
There were no significant changes in energy (2252±569 vs 2228±667kcal; t=0.17, d.f.=14, NS) or 233 
macronutrient intake, assessed by the three-day food diaries, with the exercise intervention.  234 
 235 
Plasma metabolites and hormones and insulin sensitivity 236 
- Fasting plasma levels and insulin sensitivity 237 
One outlier was removed due to abnormally high levels of AG plasma levels at baseline (214.5 pmol/L 238 
for fasting and 44655 pmol/L*min for postprandial total AUC (3.4 and 3.5 SDs away from the mean, 239 
respectively)). The fasting plasma levels of the metabolites and hormones measured and insulin 240 
sensitivity, before and after the 12-week exercise intervention are displayed in Table 2. 241 
The exercise intervention resulted in a significant reduction in insulin and a significant increase in AG 242 
fasting plasma levels (t=3.49, d.f.=14, P=0.004; t=-2,960, d.f.=13, P=0.011, respectively), but no 243 
significant changes in glucose, TG, GLP-1 or PYY fasting plasma levels. The exercise intervention 244 
resulted also in a significant increase in fasting SI (t=-5.37, d.f.=13, P<0.0001).  245 
 246 
- Postprandial plasma levels  247 
Glucose and insulin  248 
A significant main effect of time (F(1.720, 17.197)=9.951, P<0.0001), but no effect of exercise or 249 
interaction was observed on glucose plasma levels, which increased from breakfast until t=30 min and 250 
decreased afterwards (data not shown). A significant effect of time (F(1.895, 23.819)=25.53, 251 
P<0.0001) and exercise (P<0.05), but no interaction, was observed in insulin plasma levels (Fig. 1). 252 
Insulin plasma levels increased from breakfast until t=45 min and decreased afterwards and were 253 
significantly lower after the exercise intervention. 254 
 255 
 256 
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Appetite-related hormones  257 
A significant main effect of time (F(7, 91)=21.565, P<0.0001), but no effect of exercise or interaction 258 
was observed on TG plasma levels, which decreased from breakfast until t=90 min and increased 259 
progressively afterwards (Fig. 2). The amplitude of change in TG plasma levels (peak – nadir) 260 
increased, on average, 30% with the exercise intervention (204±123 vs 261±151 pmol/L), but this was 261 
not significant (t=-1.519, d.f.=14, P=0.151).  262 
No significant effects of time, exercise or exercise*time interaction were observed on AG plasma 263 
levels (Fig. 2). However, a closer analysis of the data revealed no significant effect of time at baseline 264 
between fasting at t=90 minutes (F(2.57, 30.79)=3.14, P=0.05), but a significant effect of time 265 
(suppression) at the end of the intervention (F(1.62, 19.42)=9.79, P=0.002). Moreover, a significant 266 
increase (127%) in the amplitude of change in AG plasma levels (peak – nadir) was observed with the 267 
exercise intervention (12.4 ± 11.1 vs 28.1 ± 21.4 pmol/L, t=-3.061, d.f.=13, P=0.009).  268 
A significant effect of time (F(2.599, 33.781)=12.839, P<0.0001), but no main effect of exercise or 269 
interaction was observed on GLP-1 plasma levels (see Fig. 3). Total GLP-1 AUC (fasting up to 180 270 
min) did not change with the exercise intervention, but there was a tendency for a higher GLP-1 AUC 271 
on the last 90  (90-180 min) and 60 postprandial minutes (120-180 min) after the 12-week exercise 272 
intervention compared with baseline (1491±365 vs 1689±430 pmol/L*min, t=-2.242, d.f.=14, P=0.042 273 
and 991±231 vs 1126±248, t=-2.388, d.f.=14, P=0.032, respectively). 274 
A significant effect of time (F(3.291, 42.789)=10.802, P<0.0001), but no effect of exercise or 275 
interaction was observed on PYY plasma levels (see Fig. 3). Total PYY AUC (fasting up to 180 min) 276 
did not change with the exercise intervention, but there was a tendency for higher PYY AUC between 277 
120-180 min after the 12-week exercise intervention compared with baseline (798±224 vs 888±211, 278 
t=-1.770, d.f.=14, P=0.099). 279 
 280 
Subjective feelings of appetite 281 
Fasting state 282 
There was a significant increase in fasted subjective feelings of hunger (4.1±1.6 vs 6.5±2.5cm, t=-283 
3.126, d.f.=14, P<0.01), desire to eat (4.8±1.5 vs 6.4±2.3cm, t=-2.604, d.f.=14, P<0.05) and 284 
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prospective food consumption (6.0±1.6 vs 7.1±2.0cm, t=-2.286, d.f.=14, P<0.05), and a significant 285 
reduction in fullness feelings (3.5±1.1 vs 1.9±1.5cm, t=3.261, d.f.=14, P<0.01) after the 12-week 286 
exercise intervention. 287 
 288 
Postprandial state 289 
A significant effect of time (F(3.039, 42.553)=20.910, P<0.0001) and exercise (F(1, 14)=10.901, 290 
P<0.01) was observed on subjective feelings of hunger, which increased after the 12-week exercise 291 
intervention compared with baseline levels (see Figure 4). A significant effect of time (F(3.425, 292 
47.944)=30.693, P<0.0001) and a time*exercise interaction (F(3.908, 54.707)=4.319, P<0.01), but no 293 
main effect of exercise, was observed on subjective feelings of fullness (see Figure 4). A significant 294 
effect of time (F(7, 91)=16.724, P<0.0001) and exercise (F(1, 13)=5.517, P<0.05) was also observed 295 
on subjective feelings of desire to eat, with a similar pattern to that described for hunger feelings (data 296 
not shown). A significant effect of time (F(2.716, 38.027)=17.846, P<0.0001), but no main effect of 297 
exercise or interaction was observed on subjective feelings of prospective food consumption (data not 298 
shown). 299 
There was a significant increase in the total AUC for hunger (530±310 vs 720±342cm*min, t=-2.920, 300 
d.f.=14, P<0.05) and desire to eat scores (601±352 vs 794±375cm*min, t=-2.331, d.f.=14, P<0.05) 301 
with the exercise intervention, but no significant change in total AUC for fullness (988±375 vs 302 
1001±324cm*min, t=-0.149, d.f.=14, P>0.05) or prospective food consumption (937±460 vs 303 
998±396cm*min, t=-0.805, d.f.=14, P>0.05). 304 
 305 
Relationships amongst weight loss changes, subjective appetite sensations and plasma levels of 306 
appetite-related hormones   307 
There was a large variability in exercise-induced weight loss and body composition changes (fat mass 308 
(FM and FFM)) ranging from –5.9 to -1.2 kg for body weight, -5.2 to -0.6 for FM and -4.0 to +2.7 kg 309 
for FFM. Weight loss was not correlated with baseline (pre-intervention) appetite sensations or 310 
appetite-related hormone plasma levels or with the changes experienced in response to the exercise 311 
programme. 312 
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Discussion 313 
To the best of our knowledge, this is the first study to assess the impact of a medium-term supervised 314 
exercise programme on fasting and postprandial plasma levels of both orexigenic (TG and AG) and 315 
anorexigenic peptides (GLP-1 and PYY) involved in appetite control, in sedentary overweight/obese 316 
individuals. We have shown that even though 12 weeks of exercise, inducing an average 3.5 kg 317 
weight loss,  significantly increase fasting AG plasma levels and subjective feelings of hunger, it also 318 
lead to a tendency for an increase in late postprandial release of GLP-1 and a significant increase in 319 
the amplitude of change of AG in response to a fixed meal. It is important to note that because 320 
participants were asked not alter their food intake, some dietary restraint was exerted which in turn 321 
could have contributed to the outcome. Therefore, the observed changes could not be attributed 322 
exclusively to exercise-induced weight loss. Moreover, although it can be argued that the test meal 323 
used might not have been large enough to induce significant changes in appetite-related hormones, the 324 
energy content of our test meal was higher than that used in other appetite studies (18;19). 325 
Previous studies on the impact of exercise-induced weight loss on appetite-related hormones have 326 
reported an increase (8-10) or no change in fasting TG plasma levels (20) and no change in fasting AG 327 
plasma levels (10;11); however none had previously measured simultaneously changes in fasting and 328 
postprandial plasma levels of TG and AG in overweight and obese adults. Moreover, the only 329 
available studies on the impact of chronic exercise on the release of satiety peptides are limited by 330 
their short duration (5 days of exercise) (12) and absence of postprandial blood sampling (11). The 331 
fact that in these two studies no significant change in body weight were observed (11;12), makes it 332 
difficult to compare with the results of the present investigation. 333 
We hypothesize that the type and magnitude of counter-regulatory adaptations in response to weight 334 
loss is likely to differ depending on the type of weight loss intervention. There is some evidence to 335 
suggest that diet-induced weight loss is associated with a compensatory increase in TG plasma levels 336 
and a blunted postprandial release of PYY and GLP-1 (6;19). Our findings suggest that exercise-337 
induced changes are different. Exercise-induced weight loss may increase the drive to eat, as shown by 338 
increased levels of AG and subjective feelings of hunger in fasting, but it may also improve satiety 339 
consistent with the tendency towards an increase in the late postprandial release of GLP-1. These 340 
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findings are in line with our previous observation that even though medium-term exercise-induced 341 
weight loss increases both fasting hunger and hunger across the day, it also improves the satiety 342 
efficiency of a breakfast (as shown by a significant increase in the satiety quotient) (21). Moreover, we 343 
have shown here that the suppression of TG and AG in response to food intake (calculated as 344 
amplitude: peak – nadir) increases with exercise, although only significantly for AG. The increase in 345 
the amplitude of change of AG observed with the exercise intervention was due to the increase in 346 
fasting AG and not to a more pronounced decrease after the breakfast meal. However, it is important 347 
to acknowledge that prior to the exercise intervention, when participants were sedentary; AG plasma 348 
levels were irresponsive to food intake. This pattern was changed after 12 weeks of exercise with an 349 
associated 3.5 kg average weight loss. Unfortunaly reports on the impact of weight loss or changes in 350 
physical activity levels on the postprandial release of AG are limited and from our knowledge only 351 
one study has looked at the role of body weight on AG postprandial secretion (18). Zwirska-Korczala 352 
et al (18) reported a significant suppression of AG following the ingestion of a mixed meal in normal 353 
weight women, but not in moderately or morbidly obese women with the metabolic syndrome. These 354 
findings are consistent  with our results and suggest that obesity is characterised by the maintenance of 355 
high levels of AG which may supply a constant feeding drive in these individuals. We have shown that 356 
this “abnormal” pattern can be changed with exercise-induced weight loss.  357 
We have also previously reported that exercise improves the ability to adjust EI according to previous 358 
food consumption (energy compensation) in both normal-weight (22) and overweight/obese sedentary 359 
individuals (Martins, C. Kulseng, B. King, N.A. and Blundell, J.E., submitted). These findings suggest 360 
that sedentary individuals suffer from a malfunctioning or insensitive appetite control system which 361 
can be ameliorated by exercise.  362 
Another important outcome of this study was the fact that the increase in fasting AG plasma levels 363 
and hunger (as well as other appetite) sensations, in response to the 12-week exercise programme, 364 
were unrelated with the magnitude of weight loss. This finding challenges the hypothesis that these 365 
changes are part of a homeostatic compensatory mechanism to restore EB. If this was the case these 366 
changes would be expected to increase with the magnitude of weight loss. However, we are aware 367 
that our study has a small sample size and more power is required to detect such associations. 368 
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Moreover, since all our participants lost weight with the exercise intervention, it is difficult to 369 
speculate if the observed changes were a result of weight loss or exercise per se. Only a study with 370 
sufficient power and where exercise is performed in EB (by matching the energy costs of exercise 371 
with an equivalent increase in EI) and energy deficit can clearly establish if the increase in fasting 372 
hunger feelings and AG plasma levels is a result of weight loss (and therefore part of a compensatory 373 
homeostatic mechanism) or exercise.   374 
We can conclude that although exercise-induced weight loss leads to an increase in fasting AG and 375 
hunger sensations, similar to what has been reported in response to dietary-induced weight loss, 376 
exercise appears to balance this increased orexigenic drive by improving the satiety response to a meal 377 
and the sensitivity of the appetite control system.  378 
 379 
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Figure 1. Insulin plasma levels (pmol/L) over time after breakfast, before (♦) and after a 12-476 
week exercise intervention (□). Values represent means ± SEM for 15 subjects. Repeated 477 
measures ANOVA showed a significant effect of time (P<0.0001), and exercise (P<0.05), but 478 
no interactions.  479 
 480 
 481 
Figure 2. Total ghrelin (TG) (top) and active ghrelin (AG) (bottom) plasma levels (pg/mL) 482 
over time after breakfast, before (♦) and after a 12-week exercise intervention (□). Values 483 
represent means ± SEM for 15 subjects. Repeated measures ANOVA showed a significant 484 
effect of time (P<0.0001), but no effect of exercise or interactions for TG and no significant 485 
main effect of time, exercise or interactions for AG.  486 
 487 
 488 
Figure 3. GLP-1 (top) and PYY (bottom) plasma levels (pmol/L) over time after breakfast, 489 
before (♦) and after a 12-week exercise intervention (□). Values represent means ± SEM for 490 
15 subjects. Repeated measures ANOVA showed a significant effect of time (P<0.0001; 491 
P=0.001), but no effect of exercise or interactions for both GLP-1 and PYY, respectively.  492 
 493 
 494 
Figure 4. Subjective feelings of hunger (top) and fullness (bottom) (cm) over time after 495 
breakfast, before (♦) and after a 12-week exercise intervention (□). Values represent means ± 496 
SEM for 15 subjects. Repeated measures ANOVA showed a significant effect of time 497 
(P<0.0001), and exercise (P<0.01), but no interactions for hunger and a significant effect of 498 
time (P<0.0001), and a time*exercise interaction (P<0.01) for fullness feelings.  499 
 500 
 
Table 1. Anthropometry, body composition and fitness levels at baseline 
and the end of the exercise intervention (n=15) 
 Baseline End 
Weight (Kg)   96.1±12.0***   92.6±11.7*** 
BMI(Kg/m2) 31.3±2.3*** 30.1±2.3*** 
Body fat (%) 35.3±5.6*** 33.5±5.9*** 
Total fat mass (Kg) 34.1±4.9*** 31.2±5.0*** 
Total free fat mass (Kg)                60.8±11.3              60.2±11.1 
RMR (kcal/day) 1830.7±317.3* 1741.7±324.9* 
Fitness level 
  VO2 max (ml/Kg/min) 
 
32.9±6.6*** 
 
37.7±5.9*** 
BMI – Body mass index; RMR – Resting metabolic rate; VO2 – Maximum oxygen uptake.  
Results expressed as mean ± SD. Means sharing the same symbol denote significant 
differences between baseline and end :  * P<0.05, ***P<0.0001 
 
 
 
 
 
Table 2. Fasting plasma levels of metabolites and hormones and insulin 
sensitivity at baseline and the end of the exercise intervention (n=15) 
 Baseline End 
Glucose (mmol/L) 5.2±0.4 5.3±0.3 
Insulin (pmol/L) 109.0±68.2** 62.8±24.8** 
Total ghrelin (pmol/L) 616.6±271 704.7±303.7 
Acylated ghrelin (pmol/L) 37.2±18.2* 51.7±26.0* 
GLP-1 (pmol/L) 12.8±6.1 11.7±2.3 
PYY (pmol/L) 10.6±5.5 10.3±4.8 
SI (%) 69.5±50.4*** 99.4±51.8*** 
Results expressed as mean ± SD. Means sharing the same symbol denote significant 
differences between baseline and end (within the same group):  * P<0.05, ** P<0.01, 
***P<0.0001 
SI (%) - fasting insulin sensitivity as a percentage of a normal reference population 
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